Search - tctmd.com

Displaying 41 - 60 of 2790

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1269: Associations Between AI Based-Quantitative Coronary Plaque Analysis, Calcium Score, and ASCVD Score with Major Adverse Cardiovascular Events: An Observational Study from Piedmont Heart Institute CCTA Registry

Presenter: Venkateshwar Polsani

October 28, 2025

Presentation TCT 2025

TCT 200: Association between the Occurrence of Coronary In-Stent Restenosis in Post-Renal Transplant Recipients and Adverse Cardiovascular Events

Presenter: Aakash Rana

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

Presentation TCT 2025

TCT 943: Predictors of adverse events in Patients with Premature Coronary Artery Disease undergoing PCI

Presenter: Gaurav Kumar Arora

October 27, 2025

Presentation TCT 2025

TCT 433: Can Major Cardiovascular Adverse Events (MACE) be Predicted? A Systematic Review and Meta-Analysis Exploring the Use of Machine Learning (ML) with Coronary Computed Tomography Angiography (CCTA)

Presenter: Saif Syed

October 27, 2025

Presentation TCT 2025

TCT 534: Circulatory Assist Devices in HFrEF: Assessing 30-Day Major Adverse Cardiovascular Events and Clinical Outcomes

Presenter: Mohamed Elhussain

October 27, 2025

Presentation TCT 2025

TCT 1077: A New GRACE Score for Predicting Adverse Cardiac Events After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

Presenter: Xiaofei Gao

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

News Conference News TCT 2025

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Caitlin E. Cox

October 26, 2025

Presentation TCT 2025

TCT 1256: Integrating Fractal Analysis with Deep Learning Models for Predicting 30-Day Major Adverse Cardiovascular Events

Presenter: Venkat Krishnamoorthy

October 26, 2025

Presentation TCT 2025

TCT 906: Adverse Events in Percutaneous Transmural Arterial Bypass Using the Detour System: A MAUDE Database Review

Presenter: Sami Dalati

October 26, 2025

Presentation TCT 2025

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

Presenter: Mahsa Rezasoltani

October 26, 2025

Presentation TCT 2025

TCT 748: Effects of SGLT2 Inhibitors on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus Undergoing Transcatheter Mitral Valve Repair: A Propensity-Matched Analysis

Presenter: Mahmoud Abdelnabi

October 25, 2025

Presentation TCT 2025

TCT 20: Clinical Outcomes, Adverse Events, and Healthcare Utilization in Elective Versus Non-Elective Transcatheter Aortic Valve Replacement: National Trends

Presenter: Chaitanya Tumuluri

October 25, 2025

Presentation TCT 2025

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

Presenter: Grant William Reed

October 25, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Caitlin E. Cox

October 22, 2025

News Daily News

Prenatal Hyperlipidemia: ‘Canary in a Coal Mine’ for Maternal Health?

L.A. McKeown

October 17, 2025

Advertisement

TCT 1269: Associations Between AI Based-Quantitative Coronary Plaque Analysis, Calcium Score, and ASCVD Score with Major Adverse Cardiovascular Events: An Observational Study from Piedmont Heart Institute CCTA Registry

TCT 200: Association between the Occurrence of Coronary In-Stent Restenosis in Post-Renal Transplant Recipients and Adverse Cardiovascular Events

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

TCT 943: Predictors of adverse events in Patients with Premature Coronary Artery Disease undergoing PCI

TCT 433: Can Major Cardiovascular Adverse Events (MACE) be Predicted? A Systematic Review and Meta-Analysis Exploring the Use of Machine Learning (ML) with Coronary Computed Tomography Angiography (CCTA)

TCT 534: Circulatory Assist Devices in HFrEF: Assessing 30-Day Major Adverse Cardiovascular Events and Clinical Outcomes

TCT 1077: A New GRACE Score for Predicting Adverse Cardiac Events After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

TCT 1256: Integrating Fractal Analysis with Deep Learning Models for Predicting 30-Day Major Adverse Cardiovascular Events

TCT 906: Adverse Events in Percutaneous Transmural Arterial Bypass Using the Detour System: A MAUDE Database Review

TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis

TCT 748: Effects of SGLT2 Inhibitors on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus Undergoing Transcatheter Mitral Valve Repair: A Propensity-Matched Analysis

TCT 20: Clinical Outcomes, Adverse Events, and Healthcare Utilization in Elective Versus Non-Elective Transcatheter Aortic Valve Replacement: National Trends

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Prenatal Hyperlipidemia: ‘Canary in a Coal Mine’ for Maternal Health?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content